Abstract
Mild cognitive impairment (MCI) is a prevalent age-related health concern that signifies a transitional phase between normal cognitive aging and early dementia, with Ayurveda correlating it to Jarajanya Smrthibramsa linked to aging and aggravated Vata Do?a. Its prevalence increases with age, affecting up to 25.2% of individuals aged 80-84. While early detection and interventions are essential, FDA-approved pharmacological treatments remain lacking. Ayurvedic modalities such as Rasayana therapies can provide a viable strategy for managing MCI. In this narrative review, studies investigating the effects of Rasayana on MCI were evaluated. A broad search strategy was employed using several online databases, covering articles from January 2000 to July 2024, resulting in the assessment of 23 articles. Evidence-based studies in Rasayana therapy have examined improvements in nutritional quality, cerebral metabolism, and microcirculation, all of which support neuroprotection and cognitive function. This review underscores the direct and indirect roles of Ayurveda Rasayana in the management and prevention of MCI.
Keywords
Mild Cognitive Impairment, Jarajanya Smrthibramsa, Rasayana
DOI
View DOI - (https://doi.org/10.36713/epra24697)
How to Cite:
Dr. Sinsha.A.S, Dr. Midhila.K.J , EVIDENCE BASED OUTCOMES OF RASÄYANA THERAPIES FOR MILD COGNITIVE IMPAIRMENT IN THE ELDERLY: A NARRATIVE REVIEW , Volume 11 , Issue 10, October 2025, EPRA International Journal of Multidisciplinary Research (IJMR) , DOI: https://doi.org/10.36713/epra24697